AURO-DAPAGLIFLOZIN / METFORMIN
AURO-DAPAGLIFLOZIN / METFORMIN
Approved
DIN Number
02533073
Drug Class
Human
Market Date
May 16, 2023
Company
HC
auro pharma inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02533073
AIG Number0257650001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BD15 METFORMIN AND DAPAGLIFLOZIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.04
Health Canada Classification
ACTIVE INGREDIENTS (2)
DAPAGLIFLOZINActive
Strength: 5 MG
Monograph: DAPAGLIFLOZIN
METFORMIN HYDROCHLORIDEActive
Strength: 850 MG
Monograph: METFORMIN HYDROCHLORIDE